PCOS
PCOS
PCOS
Of
(REPERTORY)
OF
At
By
ISHA ARORA
Session : 2013-2016
7. AIM
To evaluate the utility of Homoeopathic Medical Repertory by Robin Murphy in managing
of Polycystic ovarian Syndrome.
OBJECTIVE
To manage the cases of Polycystic ovarian Syndrome.
To evaluate group of Homoeopathic medicines effective in treating Polycystic ovarian
Syndrome
8. REVIEW OF LITERATURE
PCOS is a hormonal condition, not a problem with the ovaries. Ultrasound is NOT enough
to diagnose PCOS. 25% of perfectly normal women display polycystic ovaries at one time
or other .15 A subsequent ultrasound will show it to be normal again. True PCOS involves
hormone irregularities that must be picked up with blood test.
Many cases of PCOS are temporary. More specifically, many cases of so-called PCOS that
we see in our clinic can more accurately be described as post-Pill syndrome. It is a
medically recognized fact that it can take up to 2 years for normal ovulation to resume after
stopping the Pill. (16-18) .It is important to understand a normal ovary produces fluid-filled
follicles that contain the eggs. Ovarian 'cysts' form and are reabsorbed every month, in
every woman. Follicles of different number and different size will be visible in every
ovary. When the follicles do not form properly cyst is actually being formed. Follicles can
be too large (a type of 'ovarian cyst' that can cause pain or rupture), or too small (as seen is
polycystic ovaries). The 'cysts' seen in PCOS are actually small, underdeveloped
follicles. They look like that because ovulation is not occurring properly, and this can be
due to a number of causes, but in true PCOS, it is due to a problem with insulin.
The polycystic appearance may be normal. Or the ovaries may look that way because
something is preventing ovulation from progressing normally.
Type 1 PCOS: Insulin-resistant
The real underlying issue is insulin resistance and leptin resistance. Improper signaling
from these metabolic hormones inhibits ovulation and causes the ovaries to produce
testosterone. It is a problem with the metabolic hormones that causes weight gain.
Type 2 PCOS: Non-insulin-resistant
The ultrasound may show multiple, undeveloped follicles. LH may be elevated, and periods
do not occur regularly. Testosterone may be high or normal. If testosterone is normal, the
acne and facial hair exist because oestrogen is too low (compared to testosteorne). Body
weight can be normal.
In insulin-resistant Type 1 PCOS, the ovaries were prevented from ovulating because of
insulin. In type 2 PCOS; the ovaries are prevented from ovulating because of something
else.
A recent German study has found that PCOS sufferers have an increased risk for
autoimmune thyroid disease.(19)
The researchers believe that the progesterone deficiency associated with PCOS makes
women more susceptible to the autoimmune condition. It may also be that women with
thyroid conditions are more like to develop PCOS. Healthy thyroid function is necessary
for healthy ovulation.
"As [PCOS patients] get older, their chance of getting pregnant may actually be higher,"
according to Swedish researcher Miriam Hudecova. Her research shows that by the age of
35, women with PCOS have had as many successful pregnancies as women without PCOS,
even without the assistance of fertility treatment. (20)
Symptoms
Women with polycystic ovary syndrome may display a wide range of clinical
symptoms but they usually present for three primary reasons: menstrual irregularities,
infertility and symptoms associated with androgen excess (e.g., hirsutism and acne). In one
study, 70 percent of affected women reported menstrual dysfunction. A smaller percentage
of women with polycystic ovary syndrome actually have normal cycles..
Clinical signs include those associated with a hyperandrogenic anovulatory state. Hirsutism
and acne are common. Approximately 70 percent of affected women manifest growth of
coarse hair in androgen-dependent body regions (e.g. chin, upper lip, periareolar area,
chest, lower abdominal midline and thigh), as well as upper-body obesity with a waist-to-
hip ratio of greater than 0.85. Obesity is present in up to 70 percent of patients. Ovarian
enlargement may be unilateral or absent .
Diagnosis
To diagnose PCOS, a combination of clinical symptoms and lab tests. The blood tests to
consider are:
Free testosterone - elevated in PCOS.
DHEA -S- elevated in PCOS.
Sex hormone binding globulin (SHBG) - usually low in PCOS.
Fasting insulin - elevated in PCOS. Results greater than 9 or 10 can indicate insulin
resistance. Insulin resistance is usually the underlying cause of PCOS. Also 2-hour
post-prandial insulin test, along with a 2-hour post-prandial glucose test.
Fasting glucose or 2-hour post-prandial glucose - elevated in PCOS. Using this
information in combination with the insulin tests helps to diagnose insulin
resistance. Also, women with PCOS have a higher risk of diabetes so it is important
to screen for this early and often.
LH: FSH- ratio between these two hormones. In PCOS, we would expect LH
(Lutenizing Hormone) to be elevated in comparison to FSH (Follicle Stimulating
Hormone).
Ultrasound to check for the presence of ovarian cysts. Even if the ovaries do appear
normal, the absence of ovarian cysts does not mean that a woman doesn't have
PCOS. Not every woman with PCOS has ovarian cysts, and not every woman with
ovarian cysts has PCOS.
Cholesterol levels and liver function tests, as these can also be abnormal in PCOS.
Complications
Untreated polycystic ovary syndrome may be regarded as a disorder that progresses until
the time of menopause. Ongoing studies lend support to the hypothesis that women with the
syndrome are at increased risk for the development of cardiovascular disease . Because the
syndrome is also associated with lipid abnormalities..
Other long-term effects of polycystic ovary syndrome are related to the clinical
consequences of persistent anovulation. These effects include infertility, menstrual
irregularities ranging from amenorrhea to dysfunctional uterine bleeding, hirsutism and
acne.
More important, the long-term effects of unopposed estrogen place women with the
syndrome at considerable risk for endometrial cancer, endometrial hyperplasia and,
perhaps, breast cancer..
HOMOEOPATHIC APPROACH
Homeopathy is the dominant option to treat Polycystic Ovarian Syndrome. Homeopathic
approach towards management of PCOS is constitutional taking into account the patient’s
physical symptoms along with their mental and genetic makeup that individualizes the
person. Early intervention with Homeopathy can assist in preventing further progress and
hence deterioration caused by PCOS. Homeopathic constitutional treatment will help
balance hyperactivity of the glands, regulate hormonal balance, dissolve the cysts in the
ovaries and force them to resume normal functioning. Hence, Homeopathic medicines can
restore hormonal balance, normal ovulation, menstrual cycles, and also eliminate the need
for hormone therapies and surgery. This can significantly increase the chances of
conception.
Several researchers in Polycystic Ovarian Syndrome has been done , one of the research
published in Boletin Mexicano de Homeopatica14 in which 36 women suffering from
Polycystic Ovary Syndrome (PCOS), and fitting the mental picture of the homoeopathic
remedy Pulsatilla, were given Pulsatilla 6C, 4 hourly throughout the day for 2 weeks after the
end of menstruation, and this was repeated for 4 consecutive cycles.
Many stalwarts’ of Homeopathy and authors have suggested certain medicines for
providing permanent relive to the patients and also to control the acute episodes.
The Homoeopathic Medical Repertory by Robin Murphy is based on the principles of
clinical as well as classical homoeopathic practice. The author’s aim to make it modern
practical and easy reference book . He has enriched this repertory with many clinical as
well as pathological rubrics & which helps the practitioner to find out simillinum on the
basis of clinical and classical symptoms There are 3 typographies used in this Repertory to
indicate the gradation of remedies CAPITAL BOLD :3, Italics : 2, Roman:1
RUBRICS FOR Polycystic ovarian syndrome –
1. Female Cyst, genitalia-cysts,ovarian
Left
Right
2.Amenorrhea, menses absent(see suppressed)
Girls in young
3.Constitution, distribution masculine in women
4. Obesity uterine complaints with
Inclusion Criteria -
1) Diagnosed cases of PCOS.
2) Females of age groups of 1 5 – 30 years.
3) Patients complying with regular follow up.
Exclusion Criteria –
9.5) Intervention
Homoeopathic Medicines as per the totality of each case.
11 REFERENCES:
1. Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in
South Indian Women Using AES-2006 Criteria) ,Thathapudi S, Kodati V, Erukkambattu
J, Katragadda A, Addepally U, Hasan Q 2014 Jan 5 12(1): e12470
2.Niddi R, Padmalatha V, Nagarathna R , Amritanshu R . Prevalence of polycystic Ovarian
syndrome in Indian Adolesc Gynecol. 2011; 24; 223-7
3.Chhabra S, Venkatraman S . Menstrual dysfunction in rural young women & the presence
of Polycystic ovarian syndrome. J obstet gynaecol . 2010 Jan, 30(1) ; 41-5
4 Ovary syndrome (pcos) in urban india, Heidi Ann Manlove ,2011,University of Nevada,
Las Vegas
5. Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI, Salahuddin M. Epidemiologic
& etiologic aspects of hirusitism in Kashmiri Women in the Indian Subcontinent . Fertil
Steril. 2002; 77(4): 674-8
6 Rotterdam ESHRE/ ASRM – Sponsored PCOS consensus workshop group, Revised 2003
consensus on diagnostic Criteria and long term health risks related to polycystic ovary
syndrome . Fertil Steril 2004; 19-25
7. Azziz R, Carmina E, Dewailly D , Diamanti – kandarakes E , Escobar- Morreale HF,
Futterweitw, etal. Positions statements : Criteria for defining polycystic ovary syndrome as
a predominantly hyperandrogenic syndrome: an Andogen Excess Society guideline, Jelin
Endocrinal Metabolic 2006; 91(11) : 4237-45
8. Dunaif A, Givens J Haseltine F, Merriam G , editors Polycystic ovary syndrome Boston ,
MA : Blackwell Scientific Publications ,1992
9 Anthropometric and Biochemical Characteristics of Polycystic Ovarian Syndrome in
South Indian Women Using AES-2006 Criteria) Thathapudi S, Kodati V, Erukkambattu
J, Katragadda A, Addepally U, Hasan Q 2014 Jan 2014 Jan 5; 12(1): e12470
10.A Detailed Study on Poly Cystic Ovarian Syndrome and It’s Treatment With Natural
Products ,Nagarathna P.K.M, Preethy Rachel Rajan, Raju Koneri, 2013; 5(4): 109-120
11.Speroff L, DeCherney A. Evaluation of a new generation of oral contraceptives.
ObstetGynecol.1993;81:1034–47
12.Petiti D, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel H. Stroke in users of low-
dose oral contraceptives. N Engl J Med. 1996; 335:8–15.
13.Alternative Treatment of Ovarian Cysts with Tribulus terrestris Extract: A Rat Model,
onlinelibrary.wiley.com/doi/10.1111/j.1439
14 Sanchez-Resendiz J., Guzman-Gomez F., Polycystic Ovary Syndrome. Boletin
Mexicano de Homeopatica, 30, 1997, 11-15.
15 Polson DW et al. Lancet. Polycystic ovaries--a common finding in normal women.1988
Apr 16;1(8590):870-2.
16 Gnoth, C et al. Cycle characteristics after discontinuation of oral contraceptives.
Gynecol Endocrinol 2002:16(4): 307-17.
17Vessey, M et al. Return of Fertility after discontinuation of oral contraceptives: influence
of age and parity. The British Journal of Family Planning. 1986: 11: 120-124.
18Nader, S et al. The effect of desogestrel-containing oral contraceptives on the glucose
tolerance and leptin concentration in hyperandrogenic women' J Clin Endocrinol Metab
1997 82: 3074-7
19 Janssen OE. High prevalence of autoimmune thyroiditis in patients with polycystic
ovary syndrome. Eur J Endocrin 150(3): 363-369
20 . Long-term follow-up of patients with polycystic ovary syndrome: reproductive
outcome and ovarian reserve. M. Hudecova1, J. Holte, M. Olovsson, and I. Sundstro¨m Poromaa,
Human Reproduction, Vol.1, No.1 pp. 1–8, 2009 doi:10.1093/humrep/den482
14 PARTICULARS OF GUIDE
14.3)Signature:
15.2) Address:
15.3) Signature:
16.3 Signature
17 17.1 REMARKS OF THE PRINCIPAL / HEAD OF THE INSTITUTION:
17.2 Signature:
Seal: